Ryo Yamamoto - Concepedia

Author

Ryo Yamamoto

Also Known As

R Yamamoto, R. Yamamoto, R., Yamamoto, RYO YAMAMOTO, Randall Yamamoto, Risako Yamamoto, Ryo YAMAMOTO, Ryo Yamamoto, Ryo yamamoto, Yamamoto, Ryo

182

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Keio University Jikei University School of Medicine Tohoku University Tokyo Dental College Ichikawa General Hospital The University of Osaka

About

Ryo Yamamoto is an author at Keio University specializing in medicine, emergency medicine, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	464
2	Public Health	2	2	56
3	Health Sciences	1	1	19
4	Social Sciences	1	1	17
5	Critical Care Medicine	1	1	85

Ryo Yamamoto

Publications

966

Citations

H-Index

Page 1

	Year	Citations
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J‐SSCG 2020) Moritoki Egi, Hiroshi Ogura, Tomoaki Yatabe, Acute Medicine & Surgery Trauma ResuscitationJ-sscg 2020Hospital MedicineCritical Care MedicineClinical Epidemiology	2021	85
Resuscitative endovascular balloon occlusion of the aorta (REBOA) is associated with improved survival in severely injured patients: A propensity score matching analysis Ryo Yamamoto, Ramón F. Cestero, Masaru Suzuki, The American Journal of Surgery Improved SurvivalCardiovascular DiseaseEndovascular TechniqueVascular SurgeryOutcomes Research	2019	61
Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment Ryo Yamamoto, Yasushi Otsuka, Masaaki Nakayama, Clinical and Experimental Nephrology Peritoneal SclerosisHemodialysisKidney TransplantKidney FailureChronic Kidney Disease	2005	60
Hydrogen gas distribution in organs after inhalation: Real-time monitoring of tissue hydrogen concentration in rat Ryo Yamamoto, Koichiro Homma, Sayuri Suzuki, Scientific Reports	2019	59
High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment. Ryo Yamamoto, Masaaki Nakayama, Toshio Hasegawa, PubMed Peritoneal SclerosisEarly DevelopmentDialysisHigh-transport MembraneDialysis Therapy	2002	54
Novel haemodialysis (HD) treatment employing molecular hydrogen (H2)-enriched dialysis solution improves prognosis of chronic dialysis patients: A prospective observational study Masaaki Nakayama, Noritomo Itami, Hodaka Suzuki, Scientific Reports	2018	48
Risk factors and preventive measures for encapsulating peritoneal sclerosis--Jikei experience 2002. Masaaki Nakayama, Hiroyasu Yamamoto, Masato Ikeda, PubMed Renal PathologyGastroenterologyPathologyDialysis TherapySurgery	2002	45
Clinical impact of a combined therapy of peritoneal dialysis and hemodialysis Nanae Matsuo, K Yokoyama, Yukitaka Maruyama, Clinical Nephrology	2010	43
Serum ?2 microglobulin (?2MG) level is a potential predictor for encapsulating peritoneal sclerosis (EPS) in peritoneal dialysis patients Keitaro Yokoyama, H. Yoshida, Nanae Matsuo, Clinical Nephrology	2008	33
Rapid decay of transthoracic echocardiography skills at 1 month: A prospective observational study Ryo Yamamoto, David Clanton, Ross E. Willis, Journal of surgical education Rapid DecayUniventricular FunctionCardiovascular DiseaseProspective Observational StudyThoracic Ultrasound	2017	31

Page 1